<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02396186</url>
  </required_header>
  <id_info>
    <org_study_id>CLP785</org_study_id>
    <nct_id>NCT02396186</nct_id>
  </id_info>
  <brief_title>An Assessment of the Glider Balloon in Complex Lesions</brief_title>
  <acronym>ANTELOPE</acronym>
  <official_title>An Assessment of the Glider Balloon in Complex Lesions</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>TriReme Medical, LLC</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>TriReme Medical, LLC</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to collect data from real-world use with the Glider Percutaneous
      Transluminal Coronary Angioplasty (PTCA) Balloon Catheter to support the effectiveness of the
      Glider PTCA Balloon for crossing into complex coronary lesions.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Observational Study collecting data on commercial cases in which the Glider PTCA Balloon
      Catheter is used in accordance with the instructions for use. This study includes up 500
      patients at up to 50 study sites.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>March 2015</start_date>
  <completion_date type="Actual">June 2017</completion_date>
  <primary_completion_date type="Actual">June 2017</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>2 Days</target_duration>
  <primary_outcome>
    <measure>Technical Success Rate</measure>
    <time_frame>1 hour</time_frame>
    <description>Percentage of lesions successfully crossed among those attempted with the Glider PTCA catheter.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Freedom from Balloon Slippage</measure>
    <time_frame>1 hour</time_frame>
    <description>Percentage of inflations with the Glider balloon in which the physician user reports no slippage.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Lesion Success Rate</measure>
    <time_frame>48 hours</time_frame>
    <description>Percentage of lesions with &lt;50% diameter stenosis, or Thrombolysis In Myocardial Infarction (TIMI) 3 flow if side branch is present, without development of MACE during hospital stay.</description>
  </secondary_outcome>
  <enrollment type="Actual">100</enrollment>
  <condition>Coronary Artery Disease</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>PTCA Balloon Angioplasty</intervention_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        All cases of coronary interventions involving the Gliderâ„¢ PTCA Balloon Catheter at
        participating centers will be reviewed for patient eligibility. Patients from all eligible
        cases should be invited to sign an IRB-approved Informed Consent.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Lesion must be successfully crossed with a guidewire without complication (including
             Chronic Total Occlusions (CTOs))

          2. The Glider balloon may only be used at one lesion during the procedure

          3. The lesion in which the Glider balloon is used must be completed first

          4. The primary lesion treated during the procedure must be treated with the Glider
             balloon

          5. Intended treatment of a protocol-defined complex lesion that has at least one of the
             following factors:

               -  Significant vessel tortuosity

               -  Failed balloon crossing with another balloon

               -  Tight stenosis

               -  Heavy calcification

               -  Side branch present

        Exclusion Criteria:

          1. Patient &lt; 18 years of age

          2. Lesion longer than 40mm

          3. Device use not consistent with Instructions for Use

          4. Patient has not given consent for their data to be submitted to this registry
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>David Rizik, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Scottsdale Healthcare</affiliation>
  </overall_official>
  <overall_official>
    <last_name>William Lombardi, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Washington</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Alexian Brothers Heart and Vascualr Institute</name>
      <address>
        <city>Elk Grove Village</city>
        <state>Illinois</state>
        <zip>60007</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Washington University in St. Louis</name>
      <address>
        <city>Saint Louis</city>
        <state>Missouri</state>
        <zip>63110</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>York Hospital</name>
      <address>
        <city>York</city>
        <state>Pennsylvania</state>
        <zip>17403</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cardiovascular Specialists of Texas</name>
      <address>
        <city>Austin</city>
        <state>Texas</state>
        <zip>78758</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2018</verification_date>
  <study_first_submitted>March 18, 2015</study_first_submitted>
  <study_first_submitted_qc>March 23, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 24, 2015</study_first_posted>
  <last_update_submitted>September 7, 2018</last_update_submitted>
  <last_update_submitted_qc>September 7, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">September 11, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Coronary Artery Disease</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

